A61P 17 - Drugs for dermatological disorders

Patents for A61P 17 - Drugs for dermatological disorders (106,455)
10/2006
10/26/2006	US20060240056 Treatment of skin with adenosine or adenosine analog
10/26/2006	US20060240053 cosmetic or pharmaceutical composition comprising, in a physiologically acceptable medium, at least one purified natural or synthetic polypeptide wherein the peptide sequence is represented wholly or partly by at least one sequence
10/26/2006	US20060240010 Methods of modulating CD200 receptors
10/26/2006	US20060240004 Methods for treating tweak-related conditions
10/26/2006	US20060240000 Combination treatments for allergic disease comprising administering an anti-IgE antibody and antiallergic compound
10/26/2006	US20060239957 Using extract of olive leaves
10/26/2006	DE20321278U1 Cosmetic or dermatological preparation in water-in-oil emulsion form, useful to treat e.g. neurodermatitis, dyskeratoses and scars, comprises phytosterols and optionally additional materials
10/26/2006	DE20321277U1 Cosmetic/dermatological preparation in form of oil-in water emulsion, useful for treating e.g. neurodermatitis and skin aging, comprises phytosterol groups, oil components and additional materials
10/26/2006	DE102005018184A1 New phenyl ester compounds useful as antioxidants, for the reduction of skin aging, or for the prevention/treatment of inflammations, allergies and irritations of skin
10/26/2006	CA2851079A1 Vitamin k for prevention and treatment of skin rash secondary to anti-egfr therapy
10/26/2006	CA2606255A1 Use of lecithin as a medicament for treating psoriasis
10/26/2006	CA2604808A1 Method for increasing the speed of recovery and/or the speed of wound healing of injured animals
10/26/2006	CA2604604A1 Methods for treating and preventing fibrosis by il-21 / il-21r antagonists
10/26/2006	CA2603518A1 Nutrient composition for promoting collagen production
10/25/2006	EP1715035A2 Synthetic polynucleotides encoding lysyl oxidase
10/25/2006	EP1714979A2 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
10/25/2006	EP1714969A2 Immunostimulatory nucleic acid molecules
10/25/2006	EP1714675A1 Method for increasing the speed of wound healing of injured animals
10/25/2006	EP1714644A1 Pharmaceutical compositions for the treatment of ulcerations
10/25/2006	EP1458718B1 Quinolinones as prostaglandin receptor ligands
10/25/2006	EP1430053B1 AZAOXOINDOLE DERIVATIVES AS Trk PROTEIN KINASE INHIBITORS FOR THE TREATMENT OF CANCER AND CHRONIC PAIN
10/25/2006	EP1409525B1 Human papillomavirus e2 transactivation domain/inhibitor co-crystal and x-ray coordinates defining the inhibitor-binding pocket
10/25/2006	EP1265606B1 Cell adhesion inhibitors
10/25/2006	EP1187613B9 Amide substituted imidazoquinolines
10/25/2006	EP0828849B1 High-affinity oligonucleotide ligands to pdgf
10/25/2006	CN1852923A Human antibody molecules for IL-13
10/25/2006	CN1852729A Antibacterial drug for propionibacterium acnes
10/25/2006	CN1852709A Macrophage activation inhibitor
10/25/2006	CN1852708A Human beta-defensin secretion promoter
10/25/2006	CN1850273A Transparent ointment base, and its preparing method and use
10/25/2006	CN1850272A Medicine for treating alopecia areata and its clinical use
10/25/2006	CN1850233A Method for treating dermatophytosis, psoriasis, dermatitis and flat wart, and treating method
10/25/2006	CN1850224A Medicine for treating scald and burn and preparing method
10/25/2006	CN1850213A Camellia-powder composition with functions of beauty face-whitening-nourishing, anti-radiation and improving sub-health condition
10/25/2006	CN1850203A Chinese medicine preparation and ointment for treating scald and burn
10/25/2006	CN1850198A Toxin-expelling face-nourishing soft capsules and preparing method
10/25/2006	CN1850197A Toxin-expelling face-nourishing tablets and preparing method
10/25/2006	CN1850196A Toxin-expelling and face nourishing granules and preparing method
10/25/2006	CN1850175A Method for preparing Radix-paeoniae-rubra formula granules
10/25/2006	CN1850173A External ointment for curing scald and burn
10/25/2006	CN1850165A Medicine composition for treating psoriasis
10/25/2006	CN1850158A Tanshinoue dropping pills and preparing method
10/25/2006	CN1850154A Liquid capsule of Radix seu Herba Phlomis Rotatae and preparing method
10/25/2006	CN1850128A Pine pollen composition with beauty nourish function to face, intensifying immunity of body
10/25/2006	CN1850109A Gel containing betulaprenol from ginkgo leaves and its preparing method
10/25/2006	CN1850101A Compound vitamin A acid gel preparation for treating acne and its preparing method
10/25/2006	CN1850094A Compound Tara vagina-anus-cleaning liquid and its preparing method
10/25/2006	CN1850065A Use of oral conjugated linoleic acid and its derivative for increasing muscule and skin beauty
10/25/2006	CN1850025A Use of pinenut oil in preparing cosmetic
10/25/2006	CN1850021A Use of conjugated linoleic acid and its derivative for deep nourishing skin
10/25/2006	CN1281744C Maltose-trehalose converting enzyme, and preparation and uses thereof
10/25/2006	CN1281604C Substituted pyrazole compounds
10/25/2006	CN1281598C Compounds and methods for modulation of estrogen receptors
10/25/2006	CN1281590C Hexavalent amino amidate derivative with function of inhibiting blood vessel growth activity
10/25/2006	CN1281258C Cosmetic use of hop and ornithine
10/25/2006	CN1281256C Chinese medicine for treating trauma and its preparation method
10/25/2006	CN1281255C Medication for treating ulcer of lower limb of patients of skin disease and diabetic, and preparation method
10/25/2006	CN1281244C Gamboge powder for treating skin and esternal diseases
10/25/2006	CN1281242C Medicine for treating skin disease and preparation process
10/25/2006	CN1281237C Radiation-proof frost-like powder for beauty white and dispelling speckle
10/25/2006	CN1281230C Medicine composition for curing burn, scald and mucocutaneous ulcer
10/24/2006	US7125991 Compounds derived from benzoic acid esters, composition containing said compounds and use thereof
10/24/2006	US7125906 Indole derivatives having anti-angiogenetic activity
10/24/2006	US7125905 Pyrrole substituted 2-indolinone protein kinase inhibitors
10/24/2006	US7125898 Kinase inhibitors to mediate disease and as antiinflammatory agents
10/24/2006	US7125895 Arylalkylamine compounds as chemokine receptor antagonists for therapy and prevention of diseases such as arthritis or rheumatic diseases
10/24/2006	US7125890 Immunology for viral diseases and biosynthesis of cytokines of anticancer drugs for tumors
10/24/2006	US7125888 Tyrosine kinase inhibitors
10/24/2006	US7125887 Pyrrolidine modulators of CCR5 chemokine receptor activity
10/24/2006	US7125883 alpha v beta 3 integrin receptor modulators; treating variety of diseases including cardiovascular disorders, retinopathy, strokes, cancer, osteoporosis, tumor metastasis, high blood pressure, psoriasis, antiviral, antimycotic, antiparasitic or antibacterial therapy; 1,2-dihydropyrimidin-2-one moiety
10/24/2006	US7125882 Applying dimethylaminoethanol, tyrosine, and sulfur compound such as lipoic acid, glutathione, sulfur, resorcinol, resorcinol monoacetate, and/or sulfacetamide; skin sensitivity; side effect reduction
10/24/2006	US7125878 For therapy and prophylaxis of cardiovascular diseases, diabetes, diabetes- associated disorders, inflammatory diseases, immunological disorders, dermatological disorders, oncological disorders and central nervous system disorders
10/24/2006	US7125869 Drugs for cosmetics for treatment of cardiovadcular disorders, receptors, immunology or lipid metabolism
10/24/2006	US7125866 Therapeutic applications of pro-apoptotic benzodiazepines
10/24/2006	US7125839 Chimeric molecules that contain at least one pathogen-detection domain and at least one effector domain; use in preventing or treating a pathogen infection in a cell or organism
10/24/2006	US7125714 Progenitor cell materials and methods
10/24/2006	US7125699 for treating solid tumours, macular degeneration, corneal rejection, psoriasis, rheumatoid arthritis and chronic ulceration, and diseases involving vascular insufficiency, including stroke and following heart attack
10/24/2006	US7125559 Cosmetic or dermatological composition comprising a combination of an elastase inhibitor of the N-acylaminoamide family and at least one myorelaxing agent
10/24/2006	CA2300603C New compounds of the benzylaminodiacetamide family, formulations including them, preparation process and uses
10/24/2006	CA2249402C Benzopyran derivatives having leukotriene-antagonistic action
10/19/2006	WO2006109898A1 Antimicrobial composition containing natural extract, nano silver and natural essential oil
10/19/2006	WO2006109888A1 Antiwrinkle agent
10/19/2006	WO2006109867A1 PYRAZOLO[1,5-a]PYRIDINE DERIVATIVE OR MEDICALLY ACCEPTABLE SALT THEREOF
10/19/2006	WO2006109846A1 Triazole derivative and the use thereof
10/19/2006	WO2006109734A1 External agent for treating wound
10/19/2006	WO2006109671A1 Crystals of morphinan derivative and process for producing the same
10/19/2006	WO2006108666A1 Mefloquine, nelfinavir and saquinavir as novel agents for neurodegenerative and (neuro-) inflammatory diseases
10/19/2006	WO2006108414A2 Agent for use in the therapy and prophylaxis of skin diseases
10/19/2006	WO2006108318A1 A traditional chinese medicinal formulation of antidandruff and degreasing and its preparation
10/19/2006	WO2006108218A1 Use of neuropeptide y (npy) and agonists and antagonists thereof for tissue regeneration
10/19/2006	WO2006077407A3 Modulators of itch ubiquitinase activity
10/19/2006	WO2006075138A3 Il-10 related peptides for wound healing
10/19/2006	US20060235058 Substituted 5-membered ring compounds and their use
10/19/2006	US20060235054 e.g. 3-substituted 5-(4-fluorophenyl)-4-(4-pyridyl)imidazole-2-thione; immunomodulating and cytokine-release-inhibiting action; antiinflammatory agent
10/19/2006	US20060235027 Inhibitors of cdc25 phosphatases
10/19/2006	US20060235026 Quinoline-4-Carboxamide Derivatives as NK-3 and NK-2 Receptor Antagonists
10/19/2006	US20060235002 Novel physiologically active substance
10/19/2006	US20060234991 Combinations for the treatment of immunoinflammatory disorders
10/19/2006	US20060234990 Compositions of boswellic acids derived from Boswellia serrata gum resin, for treating lymphoproliferative and autoimmune conditions
10/19/2006	US20060234343 deletion of residues in the CR2 domain of the EGFR ectodomain gives rise to a truncated ectodomain with enhanced affinity for epidermal growth factors such as (EGF) and/or transforming growth factor-I (TGF- alpha ); psoriasis and tumor states

1 ... 506 507 508 509 510 511 512 513 514 515 516 517 518 519 520 521 522 523 524 525 526 ... 1065